Related Experiment Videos
Two distinct mutations at the same site in the PCCB gene in propionic acidemia
A M Lamhonwah1, C E Troxel, S Schuster
1Department of Genetics, Hospital for Sick Children, Toronto, Ontario, Canada.
Genomics
|October 1, 1990
Summary
Propionic acidemia, a metabolic disorder, involves mutations in the PCCB gene. Researchers identified two novel mutations in a patient, highlighting a critical site for enzyme function.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Propionic acidemia is an inherited metabolic disorder caused by propionyl-CoA carboxylase deficiency.
- The enzyme's alpha and beta subunits are encoded by the PCCA and PCCB genes, respectively.
Purpose of the Study:
- To identify and characterize mutations in the PCCB gene in a propionic acidemia patient.
- To investigate the functional consequences of identified mutations on enzyme activity and gene expression.
Main Methods:
- Direct sequencing of amplified reverse transcripts and genomic DNA.
- Restriction digests to analyze gene mutations.
- mRNA analysis from patient fibroblasts to assess allele expression.
Main Results:
- Two distinct mutations were identified in the PCCB gene of the propionic acidemia patient.
- One mutation involved a 3-bp deletion causing isoleucine loss in the beta-subunit.
- The other mutation resulted in a frameshift and premature stop codon due to a 14-bp deletion and 12-bp insertion.
- Fibroblast mRNA analysis indicated preferential expression of the paternal allele.
- The insertion/deletion rearrangement was found in three additional patients.
Conclusions:
- The identified mutations in the PCCB gene provide insight into the molecular basis of propionic acidemia.
- The findings underscore the functional significance of the mutation site within the PCCB gene.
- Further research is warranted to explore the prevalence and clinical impact of these specific PCCB mutations.